The company said the new product includes sales representative distribution, shipment verification, monthly inventory counts and variances, sampling status, significant loss warnings and alerts and case management applications. It also includes signature analysis and comparison.
The Prescription Drug Marketing Act (PDMA) mandates that pharmaceutical companies closely monitor the distribution, marketing and tracking of drug samples and they must be fully accountable for disbursement, inventory transactions and workflow processes in order to comply with state and federal regulations, commented Thomas Buckley, CEO of StayinFront.
StayinFront Sample Inventory Management System (SIMS) ensures that these companies have visibility into their sampling programs at any step during that process.
